Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
In conclusion, evidence from randomized trials suggests that the b/tsDMARDs studied are effective as monotherapy. In general, some patient responses seem better with combination therapy and the durability of monotherapy is less than combinat ion therapy. There is, however, a need for longer-term head-to-head trials to establish positioning of these interventions in the treatment algorithm for RA.Funding: Pfizer.Plain Language Summary: Plain language summary available on the journal website.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Abatacept | Actemra | Arthritis | Conferences | Drugs & Pharmacology | Enbrel | Humira | Methotrexate | Orencia | Pfizer | Rheumatoid Arthritis | Rheumatology | Study | Websites